(Q34580773)

3 August 2017

1 reference

title

Negative effects of antiepileptic drugs on mood in patients with epilepsy (English)

1 reference

3 August 2017

0 references

Marco Mula

1

0 references

Ley Sander

object named as

Josemir W Sander

series ordinal

2

0 references

publication date

1 January 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

30

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

555-567

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200730070-00001

3 August 2017

exact match

0 references

cites work

Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Psychiatric adverse events during vigabatrin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

New antiepileptic drugs: a systematic review of their efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Psychiatric adverse events during levetiracetam therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Discontinuation of levetiracetam because of behavioral side effects: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Hippocampal volume reduction in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200730070-00001

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

21 January 2018

1 reference

12 December 2020

Gabapentin associated with aggressive behavior in pediatric patients with seizures

1 reference

12 December 2020

Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.

1 reference

12 December 2020

Acute psychosis and EEG normalisation after vagus nerve stimulation

1 reference

12 December 2020

Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation.

1 reference

12 December 2020

Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis

1 reference

12 December 2020

Antiepileptic therapy, folate deficiency, and psychiatric morbidity: a general practice survey.

1 reference

12 December 2020

Antiepileptic drugs: indications other than epilepsy.

1 reference

12 December 2020

Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group

1 reference

12 December 2020

The psychiatric comorbidity of epilepsy.

1 reference

12 December 2020

Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination

1 reference

12 December 2020

Manic state with carbamazepine therapy of seizures

1 reference

12 December 2020

Disease modification in partial epilepsy

1 reference

12 December 2020

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

12 December 2020

Vigabatrin and psychosis

1 reference

12 December 2020

Newer antiepileptic drugs and cognitive issues

1 reference

12 December 2020

Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables

1 reference

12 December 2020

The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam.

1 reference

12 December 2020

Human Safety of Lamotrigine

1 reference

12 December 2020

Phenobarbital treatment and major depressive disorder in children with epilepsy

1 reference

12 December 2020

Antiepileptic drug-induced mania in patients with epilepsy: what do we know?

1 reference

12 December 2020

Topiramate and psychiatric adverse events in patients with epilepsy

1 reference

12 December 2020

Monotherapy or polytherapy for epilepsy?

1 reference

12 December 2020

Psychiatric syndromes related to antiepileptic drugs

1 reference

12 December 2020

Vigabatrin and behaviour disorders: a retrospective survey.

1 reference

12 December 2020

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

1 reference

12 December 2020

Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.

1 reference

12 December 2020

Primidone is associated with interictal depression in patients with epilepsy

1 reference

12 December 2020

A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy.

1 reference

12 December 2020

Forced normalization: clinical and therapeutic relevance

1 reference

12 December 2020

Use of sodium valproate in violent and aggressive behaviors: a critical review

1 reference

12 December 2020

Differences between patients with temporal lobe seizures and those with other forms of epileptic attacks

1 reference

12 December 2020

Comparative cognitive effects of carbamazepine and phenytoin in healthy adults

1 reference

12 December 2020

Behavioral side effects of gabapentin in children.

1 reference

12 December 2020

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam

1 reference

12 December 2020

Anticonvulsant drugs and cognitive functions.

1 reference

12 December 2020

Phenomenology of depression in epilepsy.

1 reference

12 December 2020

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events

1 reference

12 December 2020

Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study

1 reference

12 December 2020

Hippocampal changes in patients with a first episode of major depression.

1 reference

12 December 2020

Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a children's hospital, 1978-1983

1 reference

12 December 2020

Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy

1 reference

12 December 2020

EPILEPSY AS A CONVULSIVE DISORDER AND AS A PSYCHOSIS. ON ALTERNATIVE PSYCHOSES OF PARANOID NATURE IN "FORCED NORMALIZATION" (LANDOLT) OF THE ELECTROENCEPHALOGRAM OF EPILEPTICS

1 reference

12 December 2020

Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine

1 reference

12 December 2020

An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy

1 reference

12 December 2020

Gabapentin toxicity in children manifesting as behavioral changes.

1 reference

12 December 2020

The importance of being seizure free: topiramate and psychopathology in epilepsy

1 reference

12 December 2020

Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures

1 reference

12 December 2020

Psychotic and severe behavioural reactions with vigabatrin: a review.

1 reference

12 December 2020

Depression following withdrawal from long-term benzodiazepine use: a report of four cases

1 reference

12 December 2020

Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment

1 reference

12 December 2020

Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures

1 reference

12 December 2020

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

1 reference

12 December 2020

Clinical pharmacology and therapeutic use of the new antiepileptic drugs

1 reference

12 December 2020

Antiepileptic drugs potentiating GABA.

1 reference

12 December 2020

Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders.

1 reference

12 December 2020

Cognitive, affective, and behavioral side events in adults secondary to antiepileptic drug use.

1 reference

12 December 2020

Psychopharmacology of topiramate: from epilepsy to bipolar disorder

1 reference

12 December 2020

Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report

1 reference

12 December 2020

The neuropsychiatry of megaloblastic anaemia

1 reference

12 December 2020

Neurological aspects of folate and vitamin B12 metabolism

1 reference

12 December 2020

Behavioural effects of the newer antiepileptic drugs: an update

1 reference

12 December 2020

Vigabatrin and depression

1 reference

12 December 2020

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.

1 reference

12 December 2020

GABA and mood disorders: a brief review and hypothesis

1 reference

12 December 2020

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

1 reference

12 December 2020

The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy

1 reference

12 December 2020

International experience with tiagabine add-on therapy.

1 reference

12 December 2020

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

1 reference

12 December 2020

10.2165/00002018-200730070-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1033084803

0 references

1 reference